Inventor · disambiguated record
Alfred R. Rudolph
Also filed as: RUDOLPH ALFRED · RUDOLPH ALFRED R
8 granted patents·9 pending applications·39 citations·filing 2000–2010
82Inventor score
Files withSCICLONE PHARMACEUTICALS INC12MOSSEL ERIC C1RUDOLPH ALFRED R1SCICLONE PHARMACEUTICALS INTERNAT LTD1SICCLONE PHARMACEUTICALS INC1
Top patents by PatentIndex Score
17 records- 0179US7297676B2Thymosin alpha 1 peptide/polymer conjugatesSCICLONE PHARMACEUTICALS INC·Filed 2002·Granted Nov 20, 2007·11 cites·31 claims
- 0273US6462017B1Method of reducing side effects of chemotherapy in cancer patientsSCICLONE PHARMACEUTICALS INC·Filed 2000·Granted Oct 8, 2002·20 cites·15 claims
- 0372US7208167B2Treatment of hepatitis C with thymosin and peptide combination therapySCICLONE PHARMACEUTICALS INC·Filed 2003·Granted Apr 24, 2007·5 cites·7 claims
- 0466US8029799B2Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanomaSCICLONE PHARMACEUTICALS INC·Filed 2009·Granted Oct 4, 2011·0 cites·6 claims
- 0564US8163702B2Treatment of melanomaTUTHILL CYNTHIA W·Filed 2007·Granted Apr 24, 2012·1 cites·21 claims
- 0659US7897567B2Methods of protecting against radiation damage using alpha thymosinSCICLONE PHARMACEUTICALS INC·Filed 2003·Granted Mar 1, 2011·1 cites·21 claims
- 0758US8193152B2Treatment or prevention of hemorrhagic viral infections with immunomodulator compoundsMOSSEL ERIC C·Filed 2005·Granted Jun 5, 2012·1 cites·10 claims
- 0852US2008152668A1Thymosin Alpha 1 Peptide/Polymer ConjugatesSCICLONE PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 0950US2009074815A1Immunomodulator Compounds as Vaccine EnhancersSCICLONE PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1050US2010092499A1Alpha Thymosin Peptides as Cancer Vaccine AdjuvantsSCICLONE PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1149US2010221274A1Method of administering a thymosin alpha 1 peptideSCICLONE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 1246US8017129B2Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanomaSCICLONE PHARMACEUTICALS INTERNAT LTD·Filed 2007·Granted Sep 13, 2011·0 cites·11 claims
- 1346US2006052404A1Pharmaceutical formulations comprising substituted xanthine compoundsRUDOLPH ALFRED R·Filed 2002·Application pending·0 cites
- 1444US2005049191A1Method of administering a thymosin alpha 1 peptideSICCLONE PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 1543US2007036744A1Treatment or prevention of respiratory viral infections with alpha thymosin peptidesSCICLONE PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1641US2007087974A1Treatment or prevention of respiratory viral infections with immunomodulator compoundsSCICLONE PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1733US2010311656A1Treatment or prevention of respiratory viral infections with alpha thymosin peptidesSCICLONE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alfred R. Rudolph files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →